NMR

Nanalysis Recognized as a Top 5 Ranked Company by the TSX Venture 50 for 2021

Retrieved on: 
Thursday, February 24, 2022
TSX, Exchange, AB, TSX Venture 50, HERE, TSX Venture Exchange, Magnetic resonance imaging, The Company, MRI, Industry, Company, Consol Energy Mine Map Preservation Project, FRA, Venture, List of life sciences, NMR, Software, Multimedia, NSCI, Biotechnology, Intention, View, Technology, Motor vehicle, Cryptocurrency, Medical imaging, Mining

The selected Venture 50 companies have seen tremendous growth over 2021, offered excellent returns to their shareholders, and are actively traded in the market.

Key Points: 
  • The selected Venture 50 companies have seen tremendous growth over 2021, offered excellent returns to their shareholders, and are actively traded in the market.
  • "We are grateful to be recognized here as one of the top performers in 2021," said Sean Krakiwsky, Chief Executive Officer of Nanalysis.
  • "We have had explosive growth in our business and have no intention of our momentum slowing down in 2022 and beyond."
  • Neither TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

Nanalysis Provides Corporate Update

Retrieved on: 
Thursday, February 17, 2022
Magnetic resonance imaging, EBIDTA, Working capital, Time, GAAP, Equity, Company, CHF, Contract, Hertz, Forward-looking statement, MRI, The Company, Board of directors, Intention, Ernst & Young, EBITDA, QUAD, IFRS, NMR, Biotechnology, RFP, TSX Venture Exchange, AB, HERE, View, Board, FRA, Food, OTCQX, Software, Acquisition, Industry, Mining, Growth, Multimedia, News, Chartered Professional Accountant, Telephone newspaper, NSCI, Medical imaging, Online gambling, Security (finance), Audit, Bank, Nanalysis

CALGARY, AB, Feb. 17, 2022 /PRNewswire/ Nanalysis Scientific Corp. ("the Company", TSXV: NSCI , OTCQX: NSCIF , FRA: 1N1 ), a leader in portable NMR and MRI machines for healthcare and industrial applications, provides a corporate update and will be holding at call at 5:00pm ET today.

Key Points: 
  • CALGARY, AB, Feb. 17, 2022 /PRNewswire/ Nanalysis Scientific Corp. ("the Company", TSXV: NSCI , OTCQX: NSCIF , FRA: 1N1 ), a leader in portable NMR and MRI machines for healthcare and industrial applications, provides a corporate update and will be holding at call at 5:00pm ET today.
  • "Our growth trajectory continued though the end of 2021 and continues today," saidSean Krakiwksy, Chief Executive Office of Nanalysis.
  • On completion of the Equity Investment a second representative of Nanalysis will be appointed to Quad Systems' Board of Directors.
  • Nanalysis operates out of two subsidiaries, Nanalysis Corp. and RS2D S.A.S.

Nanalysis Scientific Corp. Closes Upsized Public Offering and Non-Brokered Private Placement For Gross Proceeds of $15,224,700

Retrieved on: 
Friday, February 11, 2022
Initial public offering, Law enforcement, TSX Venture Exchange, Indian stock exchange, Private placement, Legislation, Company, Government, SEDAR, MRI, OTC, Nuclear magnetic resonance, Private, Risk, Intention, Agrochemical, NMR, Nanalysis, AB, FRA, Marketing, Mining, Research, Multimedia, News, Exercise, Public, NSCI, Industry, Security (finance)

The Company intends to use the net proceeds of the Public Offering for sales, marketing, research and development, acquisitions, general administrative and working capital purposes.

Key Points: 
  • The Company intends to use the net proceeds of the Public Offering for sales, marketing, research and development, acquisitions, general administrative and working capital purposes.
  • The net proceeds from the Private Placement will be used for general corporate and other working capital purposes, as well as additional potential acquisitions.
  • The Common Shares issued pursuant to the Private Placement are subject to a hold period of four months plus one day from the date of closing of the Private Placement.
  • Final acceptance by the TSX Venture Exchange (the "TSXV") of the Public Offering and the Private Placement is subject to the completion of customary post-closing filings.

Nanalysis Announces Corporate Update Conference Call

Retrieved on: 
Thursday, February 10, 2022
News, Industry, Telephone call recording laws, The Company, Multimedia, TSX Venture Exchange, Intention, Software, Company, AB, ID, HERE, NMR, NSCI, Magnetic resonance imaging, Mining, Biotechnology, FRA, MRI, View, Forward-looking statement, Medical imaging

Telephonic playback will be available for 14 days after the conference call.

Key Points: 
  • Telephonic playback will be available for 14 days after the conference call.
  • Nanalysis is an international business focused on capitalizing its proprietary technologies in nuclear magnetic resonance (NMR) that go into NMR spectrometers and magnetic resonance imaging (MRI).
  • Nanalysis operates out of two subsidiaries, Nanalysis Corp. and RS2D S.A.S.
  • Nanalysis Corp. is an industry leader in developing and manufacturing compact NMR spectrometers for laboratory and industrial markets.

U.S. Food and Drug Administration Expands Deployment of Waters Corporation Software to Support its Medical Products Testing Labs

Retrieved on: 
Monday, January 24, 2022
Science, Software, Other Science, Research, Pharmaceutical, Health, FDA, Technology, Regulatory affairs, Paperwork, ORA, CDS, National archives, NYSE, WAT, Office of Global Regulatory Operations and Policy, Data management, Safety, CEO, NMR, Review, Publishing, Goal, Mass spectrometry, HPLC, National Archives and Records Administration, Waters Corporation, Food, Software, FDA, Compliance, Laboratory, LMS, Paperwork Reduction Act, Medical device, Video game console, Empower

Waters Corporation (NYSE: WAT) today announced the U.S. Food and Drug Administrations (FDA) Office of Regulatory Affairs (ORA) has purchased Waters Empower Chromatography Data Software (CDS) and NuGenesis Laboratory Management Software (LMS), expanding its deployment of Waters software to support its medical products testing operations across its five field science laboratories .

Key Points: 
  • Waters Corporation (NYSE: WAT) today announced the U.S. Food and Drug Administrations (FDA) Office of Regulatory Affairs (ORA) has purchased Waters Empower Chromatography Data Software (CDS) and NuGenesis Laboratory Management Software (LMS), expanding its deployment of Waters software to support its medical products testing operations across its five field science laboratories .
  • Both Waters software applications will provide the ORA labs a common platform for acquiring, processing, reporting, and archiving analytical data from a variety of measurement instruments.
  • The Waters Empower CDS is the worlds leading chromatography software platform with more than 250,000 licenses in use today.
  • Both Waters Empower CDS and NuGenesis LMS are available from Waters separately or as fully integrated software applications.

Nanalysis Named to 2022 OTCQX Best 50

Retrieved on: 
Monday, January 24, 2022
Forward-looking statement, News, Intention, Agrochemical, Nuclear magnetic resonance, Mining, NMR, OTCQX, Government, AB, OTC, Industry, Law enforcement, Company, Corporation, TSX Venture Exchange, MRI, Multimedia, NSCI, Compliance, Audit, Nanalysis

CALGARY, AB, Jan. 24, 2022 /PRNewswire/ - Nanalysis Scientific Corp. ( TSXV:NSCI ,OTCQX:NSCIF,FRA:1N1) ("Nanalysis" or the "Company") is pleased to announce it has been named to the 2022 OTCQX Best 50, a ranking of top performing companies traded on the OTCQX Best Market last year.

Key Points: 
  • CALGARY, AB, Jan. 24, 2022 /PRNewswire/ - Nanalysis Scientific Corp. ( TSXV:NSCI ,OTCQX:NSCIF,FRA:1N1) ("Nanalysis" or the "Company") is pleased to announce it has been named to the 2022 OTCQX Best 50, a ranking of top performing companies traded on the OTCQX Best Market last year.
  • The OTCQX Best 50 is an annual ranking of the top 50 U.S. and international companies traded on the OTCQX market.The ranking is calculated based on an equal weighting of one-year total return and average daily dollar volume growth in the previous calendar year.
  • Companies in the 2022 OTCQX Best 50 were ranked based on their performance in 2021.
  • For the complete 2022 OTCQX Best 50 ranking, visit:
    The OTCQX Best Market offers transparent and efficient trading of established, investor-focused U.S. and global companies.

OTC Markets Group Announces the 2022 OTCQX Best 50

Retrieved on: 
Monday, January 24, 2022
Bitcoin, Technology, Disclosure, BTC, Nuclear magnetic resonance, Hong Kong Stock Exchange, Mining, NMR, OTCQX, GBTC, GLOBE, ASX, OTC Markets Group, TSX Venture Exchange, CCNB, Frankfurt Stock Exchange, NSCI, Corporate services, Security (finance), Cryptocurrency, Euronext Amsterdam

NEW YORK, Jan. 24, 2022 (GLOBE NEWSWIRE) -- OTC Markets Group Inc.Markets Group Inc. (OTCQX: OTCM), operator of the OTCQX, OTCQB and Pink financial markets for over 11,000 U.S. and global securities, today announced the 2022 OTCQX Best 50, a ranking of the top-performing OTCQX companies in the prior calendar year.

Key Points: 
  • NEW YORK, Jan. 24, 2022 (GLOBE NEWSWIRE) -- OTC Markets Group Inc.Markets Group Inc. (OTCQX: OTCM), operator of the OTCQX, OTCQB and Pink financial markets for over 11,000 U.S. and global securities, today announced the 2022 OTCQX Best 50, a ranking of the top-performing OTCQX companies in the prior calendar year.
  • The 2022 OTCQX Best 50 highlights a broad range of companies traded on the OTCQX Market.
  • Three community banks were also included among this years OTCQX Best 50 list:
    Coastal Carolina Bancshares Inc (OTCQX: CCNB )
    Ten companies from last years ranking made their second appearance on the OTCQX Best 50 list in 2022.
  • Grayscale Digital Large Cap Fund LLC (OTCQX: GDLC )
    Converge Technology Solutions Corporation (OTCQX: CTSDF )
    Grayscale Bitcoin Trust (BTC) (OTCQX: GBTC )
    The 2022 OTCQX Best 50 Companies:

Proactive news headlines including Kin Mining, Meteoric Resources, Amplia Therapeutics and Alkane Resources

Retrieved on: 
Monday, January 24, 2022
MVL, SLM, Rafael, Element, Helios, Diagnosis, AVR, Proactivity, TSX, University, CGP, EM2, The Yandall Sisters, Nullarbor Plain, FGR, THV, NMR, Gold, Chalice, Patient, PAB, Mivtach Shamir Holdings Ltd., BRU, Meteoroid, Domeyko, CFO, Oracle, Leo, RAD, CRR, Tarku, OTCQB, VMS, GLOBE, ASX, CPM, OTC, Dubbo, PGE, ATX, Mining, Pharmaceutical industry, Oil, Uranium, Rare-earth element, Petroleum, Management, Norsemen

Click here

Key Points: 
  • Click here
    Mont Royal Resources Ltd (ASX:MRZ) is poised to begin its maiden fieldwork program at the recently acquired Tarku property on the Upper Eastmain Greenstone Belt in Quebec, Canada.
  • Click here
    Arovella Therapeutics Ltd (ASX:ALA) has received firm commitments from institutional and sophisticated investors to raise $4.57 million.
  • Click here
    Critical Resources Ltd (ASX:CRR) has staked an extra 700 hectares around its newly acquired Graphic Lake Project in Ontario, Canada.
  • Proactive has produced over 300,000 articles and 20,000 executive interviews since it was established in 2006
    For more information on how Proactive can help you make a difference, email us at [email protected]

Global Molecular Spectroscopy Market Trends and Forecasts to 2025 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 19, 2022
Other Science, Science, Light, Hand, NMR, Spectroscopy, Medical imaging

The "Molecular Spectroscopy Market, 2020-2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Molecular Spectroscopy Market, 2020-2025" report has been added to ResearchAndMarkets.com's offering.
  • Molecular Spectroscopy is the analysis of molecular species by measuring the interaction of light with a specific sample.
  • The Molecular Spectroscopy market comprises a very diverse range of techniques, from NMR systems that can cost millions of dollars and occupy a whole room to refractometers that cost less than $100 and can be held in the palm of a hand.
  • This in-depth analysis includes the following spectroscopy technologies:

Nanalysis Enters into a Letter of Intent to Acquire Quad Systems AG

Retrieved on: 
Tuesday, January 18, 2022
Forward-looking statement, Working capital, IP, Technology, News, Intention, GAAP, EBITDA, Agrochemical, Miniaturization, Nuclear magnetic resonance, Board of directors, IFRS, Stock, Partnership, Equity, Mining, CEO, NMR, OTCQX, Government, Bruker, OEM, OTC, Industry, Law enforcement, Company, Corporation, CHF, TSX Venture Exchange, Doctor of Philosophy, MRI, ETH Zurich, Multimedia, Letter, NSCI, Mission statement, LOI, Organization, Board, Medical imaging, Fine chemical, Security (finance), Bank, Nanalysis, Physics

CALGARY, Alberta, Jan. 18, 2022 /PRNewswire/ - Nanalysis Scientific Corp. ( TSXV:NSCI ,OTCQX:NSCIF,FRA:1N1) ("Nanalysis" or the "Company") ispleased to announce that it has entered into a letter of intent to acquire QUAD Systems AG (Quad Systems), a Zurich-based Nuclear Magnetic Resonance (NMR) company focused on high-field NMR for pharmaceutical and other vertical markets.

Key Points: 
  • CALGARY, Alberta, Jan. 18, 2022 /PRNewswire/ - Nanalysis Scientific Corp. ( TSXV:NSCI ,OTCQX:NSCIF,FRA:1N1) ("Nanalysis" or the "Company") ispleased to announce that it has entered into a letter of intent to acquire QUAD Systems AG (Quad Systems), a Zurich-based Nuclear Magnetic Resonance (NMR) company focused on high-field NMR for pharmaceutical and other vertical markets.
  • Therefore, in addition to converting our OEM relationship with Quad Systems to a closer partnership, there are also tremendous cross-selling opportunities.
  • As part of the agreement, Nanalysis has provided Quad Systems with a CHF 1,000,000 loan (Loan) which is convertible into shares in the capital of Quad Systems, and Sean Krakiwsky, founder and CEO of Nanalysis is being appointed to Quad Systems' Board of Directors as a Nanalysis nominee immediately.
  • On completion of the Equity Investment a second representative of Nanalysis will be appointed to Quad Systems' Board of Directors.